Kaplan–Meier analysis demonstrated no differences in overall survival (OS) for PD-L1 positive pRCC patients compared to those with PD-L1-negative tumor cells (Figure 4) and TIMCs (Figure 5). The gene discussed is CD274; the disease is neoplasm.